Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 27, Issue 3, Pages 332-342
Publisher
Springer Nature
Online
2013-09-13
DOI
10.1038/modpathol.2013.165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas
- (2012) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- Oligodendrogliomas
- (2012) Agustí Alentorn et al. CURRENT OPINION IN ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
- (2011) M. J. van den Bent et al. CLINICAL CANCER RESEARCH
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
- (2011) Stephen Yip et al. JOURNAL OF PATHOLOGY
- Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
- (2011) C. Bettegowda et al. SCIENCE
- Quantitative Characterization of the Interactions amongc-mycTranscriptional Regulators FUSE, FBP, and FIR
- (2010) Hsin-hao Hsiao et al. BIOCHEMISTRY
- IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
- (2010) M. J. van den Bent et al. CLINICAL CANCER RESEARCH
- Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
- (2010) Ahmed Idbaih et al. JOURNAL OF NEURO-ONCOLOGY
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas
- (2010) Lee A. D. Cooper et al. PLoS One
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss
- (2009) M. Snuderl et al. CLINICAL CANCER RESEARCH
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- Oligodendroglioma
- (2008) Martin J. Van den Bent et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
- (2008) Francois Ducray et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now